Glatopa 20 mg/mL and Copaxone® 20 mg/mL are both glatiramer acetate injections. The FDA approved Glatopa 20 mg/mL as therapeutically equivalent to Copaxone® 20 mg/mL. This means that Glatopa 20 mg/mL can be substituted for Copaxone® 20 mg/mL.
Glatopa is made in the United States.
Whether you've just been prescribed Glatopa 20 mg/mL by your doctor or have been switched from Copaxone® 20 mg/mL, you're getting the same FDA-approved treatment for your relapsing-forms of multiple sclerosis.
View this chart showing the many ways Glatopa 20 mg/mL and Copaxone® 20 mg/mL are comparable.
Everyone can appreciate a little help now and then. GlatopaCare® — our support services center — is here for you every step of the way. Simply call your GlatopaCare Representative at 1.855.GLATOPA with any questions regarding insurance information, questions about Co-Pay eligibility, or getting in touch with a Nurse Trainer for guidance with injections.